Clinical Trial Update: An Open Label Study of Chronic Polyethyleneglycol3350 Use in Constipated Patients [Phase 4]

View source ↗

Summary

Completed Phase 4 open-label study evaluating chronic use of polyethylene glycol 3350 for constipation. The study was sponsored by Braintree Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• MIRALAX (POLYETHYLENE GLYCOL 3350)

Snippet

Sponsor: Braintree Laboratories | Conditions: Constipation | Phase 4 | Status: COMPLETED